
Constellium is rated a 'Buy', with shares appearing undervalued and a calculated price target of $27.51, implying 19% upside. CSTM's record EBITDA is driven by supply shortages, favorable scrap spreads, and aerospace segment normalization, with EBITDA reaching $912M in 2026. The company's value is rooted in segment operations, not aluminum prices, due to its explicit policy of minimizing commodity exposure.










